(Bayer.com)

Bayer ex-CEO reportedly opposed Monsanto deal

Frankfurt | Reuters — Bayer ex-chief executive Marijn Dekkers opposed the company’s plans for a US$62 billion takeover of U.S. seeds firm Monsanto, German magazine Der Spiegel reported. Dekkers warned Bayer non-executive board chairman Werner Wenning against going ahead with the offer, Der Spiegel said in an excerpt of an article to be published on […] Read more






(Dave Bedard photo)

EU countries refuse to back new licence for glyphosate

Brussels | Reuters — EU nations refused to back a limited extension of the herbicide glyphosate’s use on Monday, threatening withdrawal of Monsanto’s Roundup and other weed-killers from shelves if no decision is reached by the end of the month. Contradictory findings on carcinogenic risks have thrust the chemical into the centre of a dispute […] Read more



(Bayer.com)

Bayer secures loan facility to fund Monsanto bid

Reuters — German drugs and crop chemicals group Bayer, which has made a US$62 billion bid for U.S. seeds company Monsanto, has secured a 60 billion-euro (C$87.75 billion, or US$66.9 billion) loan facility, business journal Handelsblatt reported Thursday. The loan facility can be expanded up to 75 billion euros (C$109.68 billion, or US$83.62 billion), the German […] Read more

(Bayer.com)

Monsanto rejects Bayer bid

Monsanto, the world’s largest seed company, has rejected Bayer AG’s US$62 billion acquisition bid as “incomplete and financially inadequate” but hasn’t slammed the door on further talks. Reuters on Tuesday quoted two unnamed sources as saying Monsanto can see the logic of combining with the German drugs and crop chemicals group, as per Bayer’s proposal […] Read more